期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

我如何治疗骨髓增生异常综合征 被引量：3

How I treat myelodysplastic symdromes
原文传递
导出
摘要 患者，男，39岁，因“发现白细胞减少2年，伴乏力2个月”于2011年10月10日来我院就诊。
作者 肖志坚
机构地区 中国医学科学院、北京协和医学院血液学研究所、血液病医院
出处 《中华血液学杂志》 CAS CSCD 北大核心 2017年第4期268-271,共4页 Chinese Journal of Hematology
关键词 骨髓增生异常综合征 治疗 白细胞减少
分类号 R551.3 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献5

二级参考文献25

  • 1Valent P,Horny HP,Bennett JM,et al.Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes:consensus statements and report from a working conference[J].Leuk Res,2007,31 (6):727-736.
  • 2Vardiman JW,Thiele J,Arber DA,et al.The 2008 revision of the World Health Organization(WHO) classification of myeloid neoplasms and acute leukemia:rationale and important changes[J].Blood,2009,114(5):937-951.
  • 3Schanz J,Tüchler H,So1é F,et al.New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge[J].J Clin Onco1,2012,30 (8):820-829.
  • 4Greenberg PL,Tuechler H,Schanz J,et al.Revised international prognostic scoring system for myelodysplastic syndromes[J].Blood,2012,20(12):2454-2465.
  • 5Quesnel B, Guillerm G, Vereecque R, et ah Methylation of the p15 (1NK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression [ J ]. Blood, 1998, 91 ( 8 ) : 2985-2990.
  • 6Lfibbert M, Sueiu S, Baila L, et ah Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group [J]. J Clin Oneol, 2011, 29 (15):1987-1996. doi: 10.1200/JCO.2010.30.9245.
  • 7Kantarjian H, Issa JP, Rosenfeld CS, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study [J]. Cancer, 2006, 106 (8):1794- 1803. doi: 10.1002/cncr.21792.
  • 8Kantarjian H, Oki Y, Garcia-Manero G, et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher- risk myelodysplastic syndrome and chronic myelomonocytic leukemia[J]. Blood, 2007, 109 ( 1 ):52-57. doi: 10. l 182/blood-2006-05-021162.
  • 9Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes [J]. Blood, 1997, 89(6):2079-2088.
  • 10Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes [J]. Blood, 2012, 120(12):2454-2465. doi: 10.1182/blood-2012-03- 420489.

共引文献63

同被引文献6

引证文献3

二级引证文献8

中华血液学杂志
2017年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部